Patronus Biotech Receives Ethical Approval to Begin First-in-Human Phase 1 Trial of Three Multi-Stage Vaccines Against Malaria in Australia
Bellberry Limited Research Ethics Committee approves first-in-human study in Australia of Patronus Biotech's novel multi-stage virus-like-particle (VLP)-based malaria vaccine candidates targeting Plasmodium falciparum and Plasmodium vivax GUANGZHOU, China, Oct. 20, 2026 /PRNewswire/ -- Patronus Biotech, a biotechnology company that develops next-generation vaccines to address unmet global needs, today announced that its Phase I first-in-human clinical trial NCT07831226 of three novel multi-stage VLP-based investigational vaccine candidates for malaria has received ethical approval from…
Read the full report on Pr Newswire Apac
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Pr Newswire Apac
- Reporter
- cision pr newswire
- Published
- Tuesday, 20 October 2026, 6:10 pm IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Pr Newswire Apac with a short summary and a link to the original. The original reporting belongs to the publisher. Spotted an error in our summary? Tell our corrections desk.
